| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC | 10% | 0% | $1,038,308 | +$409,747 | 1,384,410 | +65% | Mitchell P. Kopin | 30 Sep 2025 |
| Anson Funds Management LP | 7.2% | $657,143 | 952,381 | Anson Funds Management LP | 30 Sep 2025 | |||
| SEG Opportunity Fund, LLC | 7.1% | $619,048 | 952,381 | SEG Opportunity Fund, LLC | 29 Sep 2025 | |||
| RENAISSANCE TECHNOLOGIES LLC | 0.84% | -84% | $30,375 | -$153,500 | 37,500 | -83% | Renaissance Technologies LLC | 31 Dec 2024 |
As of 30 Sep 2025, 14 institutional investors reported holding 1,551,022 shares of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO). This represents 12% of the company’s total 13,227,514 outstanding shares.
The largest institutional shareholders of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Anson Funds Management LP | 7.2% | 952,381 | 0.07% | $657,143 | |
| AdvisorShares Investments LLC | 2.8% | 364,878 | +98% | 0.04% | $251,766 |
| Virtu Financial LLC | 0.81% | 107,786 | 0% | $74,000 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.3% | 39,596 | +0.74% | 0% | $27,320 |
| JANE STREET GROUP, LLC | 0.13% | 16,772 | 0% | $11,573 | |
| TWO SIGMA SECURITIES, LLC | 0.12% | 16,471 | -62% | 0% | $11,365 |
| VANGUARD GROUP INC | 0.12% | 16,334 | 0% | 0% | $11,270 |
| StoneX Group Inc. | 0.1% | 13,430 | 0% | $9,267 | |
| STATE STREET CORP | 0.09% | 12,500 | 0% | 0% | $8,625 |
| UBS Group AG | 0.07% | 8,984 | 0% | $6,199 | |
| Tower Research Capital LLC (TRC) | 0.01% | 1,707 | -1.5% | 0% | $1,178 |
| Westside Investment Management, Inc. | 0% | 94 | 0% | 0% | $65 |
| BANK OF AMERICA CORP /DE/ | 0% | 79 | +88% | 0% | $55 |
| WELLS FARGO & COMPANY/MN | 0% | 10 | 0% | $7 | |
| Federation des caisses Desjardins du Quebec | 0% | 0 | -100% | $0 | |
| CITADEL ADVISORS LLC | 0% | 0 | -100% | $0 | |
| Ursa Fund Management, LLC | 0% | 0 | -100% | $0 | |
| XTX Topco Ltd | 0% | 0 | -100% | $0 | |
| CITIGROUP INC | 0% | 0 | -100% | $0 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 1,551,022 | $1,069,833 | +$795,693 | $0.69 | 14 |
| 2025 Q2 | 406,814 | $256,292 | +$89,070 | $0.63 | 13 |
| 2025 Q1 | 247,864 | $285,030 | +$101,430 | $1.17 | 12 |
| 2024 Q4 | 182,551 | $161,999 | -$141,059 | $0.89 | 14 |
| 2024 Q3 | 337,799 | $371,282 | +$242,634 | $1.10 | 12 |
| 2024 Q2 | 119,574 | $117,878 | +$5,461 | $1.00 | 10 |
| 2024 Q1 | 112,818 | $219,125 | -$86,729 | $1.95 | 10 |
| 2023 Q4 | 160,652 | $231,338 | +$79,313 | $1.44 | 10 |
| 2023 Q3 | 105,573 | $175,734 | +$9,904 | $1.67 | 8 |
| 2023 Q2 | 99,698 | $203,640 | +$25,715 | $2.05 | 7 |
| 2023 Q1 | 87,154 | $183,307 | +$131,422 | $2.10 | 6 |
| 2022 Q4 | 21,483 | $72,276 | -$186,568 | $3.37 | 6 |
| 2022 Q3 | 50,673 | $273,000 | +$273,000 | $5.41 | 3 |